Come up with a name for your new list and we'll add to it:
LYSANDO raised a round of funding on November 12, 2014. Investors include
Siam Cement Group.
LYSANDO specializes in the development of antimicrobial proteins to combat Gram-positive and Gram-negative pathogens. LYSANDO provides solutions in a wide range of fields including hygiene, agricultur…